share_log

Harmony Biosciences | 8-K: HARMONY BIOSCIENCES REPORTS STRONG SECOND QUARTER 2024 FINANCIAL RESULTS AND ADVANCES PITOLISANT HIGH-DOSE PROGRAM TOWARD EXPECTED PDUFA DATE IN 2028

Harmony Biosciences | 8-K: HARMONY BIOSCIENCES REPORTS STRONG SECOND QUARTER 2024 FINANCIAL RESULTS AND ADVANCES PITOLISANT HIGH-DOSE PROGRAM TOWARD EXPECTED PDUFA DATE IN 2028

Harmony Biosciences | 8-K:HARMONY BIOSCIENCES公布了强劲的2024年第二季度财务业绩,并将PitoLisant高剂量计划推向了预计的2028年PDUFA日期
美股SEC公告 ·  08/06 08:18
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息